Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Exact Sciences Sees FY24 Revenue $2.81B-$2.85B Vs $2.83B Est.

Author: Benzinga Newsdesk | February 21, 2024 05:09pm

2024 revenue outlook

The company anticipates revenue of $2.810-$2.850 billion during 2024, assuming:

Screening revenue of $2.155-$2.175 billion, and
- Precision Oncology revenue of $655-$675 million

Posted In: EXAS